HERON THERAPEUTICS INC (HRTX) Stock Analyst Ratings
NASDAQ:HRTX - Nasdaq - US4277461020 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to HRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 241.9% above the current price.
HRTX was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about HRTX.
In the previous month the buy percentage consensus was at a similar level.
HRTX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-04 | Needham | Reiterate | Buy -> Buy |
| 2024-11-13 | Needham | Maintains | Buy -> Buy |
| 2024-09-25 | Needham | Reiterate | Buy -> Buy |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-06-13 | Rodman & Renshaw | Initiate | Buy |
| 2024-05-16 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-04-23 | Capital One | Initiate | Overweight |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-13 | Needham | Maintains | Buy -> Buy |
| 2023-11-15 | Needham | Maintains | Buy -> Buy |
| 2023-08-15 | Needham | Reiterate | Buy -> Buy |
| 2023-07-25 | Needham | Maintains | Buy -> Buy |
| 2023-05-12 | Needham | Maintains | Buy -> Buy |
| 2023-04-21 | Needham | Reiterate | Buy |
| 2023-03-24 | Needham | Maintains | Buy |
| 2023-03-24 | Evercore ISI Group | Maintains | Outperform |
| 2022-11-09 | Needham | Maintains | Buy |
| 2022-06-30 | Needham | Maintains | Buy |
| 2022-05-10 | Needham | Maintains | Buy |